Position in TRDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,024,523
-$6,034,424 QoQ
Shares Held
954,419
-7.8% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. TRDA ranks #82 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,024,523 | 954,419 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,058,947 | 1,034,782 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,740,111 | 1,044,758 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,535,630 | 954,419 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,128,011 | 1,060,716 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,521,958 | 1,053,314 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17,840,271 | 1,031,826 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $16,449,316 | 1,029,369 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,733,458 | 1,033,927 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,550,321 | 1,026,840 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,810,999 | 1,047,780 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $16,521,301 | 1,045,652 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $15,435,350 | 1,019,508 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,709,568 | 1,014,453 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,659,944 | 1,010,351 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,874,196 | 1,007,246 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,707,054 | 1,535,883 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $23,879,726 | 2,543,102 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $53,311,781 | 3,114,006 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||